Bronchiectasis Studies

Bronchiectasis is a chronic lung condition that affects the airways. It is a serious and often debilitating condition that makes it harder for people to breathe and fight off lung infections. 

Normal function of the lungs is disrupted, leading to a buildup of mucus that is difficult to clear. Over time, this cycle of infection and damage worsens, making the airways even more prone to problems.

Treatment typically includes antibiotics, therapies to clear mucus, and sometimes surgery. However, there are no current treatments that address the underlying inflammation effectively.

The investigational medication in this study is designed to target the proteins involved in lung inflammation, potentially reducing damage and improving breathing.

This study will evaluate how effective the study medicine is at reducing the number of severe lung flare ups, as well as how it affects overall lung function and quality of life. 

Register your interest now and find out if participating in this study is right for you. Your privacy is important to us, and all information shared will be kept confidential.

Participants will be randomly assigned to receive either the investigational product or a placebo daily for up to 76 weeks. During this time, you will visit the clinic regularly and our professional medical team will monitor your health and lung function. The study will track the number of lung flare-ups and assess lung health through breathing tests and questionnaires.

This advertisement has been reviewed and approved by the Health & Disability Ethics Committee (HDEC).